42482-94-0

Usage

InChI:InChI=1/C14H18O3/c1-3-17-14(16)6-4-5-13(15)12-9-7-11(2)8-10-12/h7-10H,3-6H2,1-2H3

Upstream product

• 108-55-4 glutaric anhydride, 
• 108-88-3 toluene 
• 64-17-5 ethanol 
• 833-85-2 5-(4-methylphenyl)-5-oxopentanoic acid 
• 5205-39-0 ethyl glutaroyl chloride 
• 4294-57-9 para-methylphenylmagnesium bromide 
• 122-00-9 para-methylacetophenone 

Downstream Products

• 833-85-2 5-(4-methylphenyl)-5-oxopentanoic acid 
• 1017209-81-2 C₁₂H₁₆O₃ 
• 1312589-93-7 C₁₄H₁₈O₃ 
• 1312589-94-8 C₁₃H₁₅NO 
• 1312589-98-2 C₁₃H₁₅NO 
• 1312589-97-1 C₁₃H₁₅NO 
• 1312589-99-3 C₁₃H₁₉NO 
• 1446350-96-4 2-methyl-6-(4-methylphenyl)hept-6-en-2-ol 
• 1446350-97-5 3,4,5,6-tetrahydro-2,2-dimethyl-6-(4-methylphenyl)-6-[(phenylselanyl)methyl]-2H-pyran 
• 42482-66-6 3,4,5,6-tetrahydro-2,2,6-trimethyl-6-(4-methylphenyl)-2H-pyran 
• 1312780-00-9 C₁₉H₂₃N₃O₃ 
• 1312780-01-0 C₂₂H₂₈N₂O₃ 
• 1312779-99-9 C₂₁H₂₇N₃O₃ 
• 1312778-84-9 C₃₁H₄₆N₆O₄S 

Relevant academic research and scientific papers

Electrochemical phenylselenoetherification as a key step in the synthesis of (±)-curcumene ether

Two variants of a new pathway for the synthesis of (±)-curcumene ether are described. The key steps in these procedures are intramolecular cyclizations of 6-methyl-2-(4-methylphenyl)hept-6-en-2-ol and 2-methyl-6-(4-methylphenyl)hept-6-en-2-ol by means of an electrochemically generated phenylselenyl cation. This synthetic approach provides significantly better yields than the previously reported protocols. Copyright

NEW CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

NOVEL ANTAGONISTS FOR CCR2 AND USES THEREOF

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) of formula (I) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

NEW CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) of Formula (I) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

NEW CCR2 ANTAGONISTS

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) of formula (Ia) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

CCR2 RECEPTOR ANTAGONISTS

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

Controlling factors determining the regiochemistry of intramolecular alkoxymercuration

The intramolecular alkoxymercuration of (E)-5-arylpent-4-en-1-ols indicated that the regioselectivity is closely related to the Hammett constants of the para-substituents on the benzene ring. Large solvent effects on the regioselectivity were also observe